SAMUEL LUCIO: Open Payments
NPI 1033634944 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,750 in 64 payments from 21 companies in 2025. Trend: 2023 $638 · 2024 $733 · 2025 $3,750
Food & beverage: $2,000Consulting: $1,750
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $1,750 |
| Novo Nordisk Inc | 16 | $499 |
| Lilly USA, LLC | 12 | $285 |
| Axsome Therapeutics, Inc. | 2 | $248 |
| AstraZeneca Pharmaceuticals LP | 4 | $169 |
| Janssen Biotech, Inc. | 1 | $144 |
| Abbott Laboratories | 2 | $102 |
| Merck Sharp & Dohme LLC | 5 | $87 |
| Inspire Medical Systems, Inc. | 2 | $79 |
| Medtronic, Inc. | 3 | $62 |
Products named: Symbravo, Ozempic, MOUNJARO, RYBREVANT, Rybelsus, ZEPBOUND, BREZTRI, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
